Aveo Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-655
| Closed | -$267K | – | 139 |
|
|
2025
Q1 | $267K | Sell |
655
-576
| -47% | -$235K | 0.04% | 152 |
|
|
2024
Q4 | $640K | Buy |
1,231
+308
| +33% | +$160K | 0.07% | 174 |
|
|
2024
Q3 | $571K | Buy |
923
+20
| +2% | +$12.4K | 0.06% | 185 |
|
|
2024
Q2 | $499K | Sell |
903
-59
| -6% | -$32.6K | 0.06% | 190 |
|
|
2024
Q1 | $551K | Buy |
962
+146
| +18% | +$83.6K | 0.06% | 202 |
|
|
2023
Q4 | $433K | Buy |
816
+72
| +10% | +$38.2K | 0.05% | 222 |
|
|
2023
Q3 | $377K | Buy |
744
+30
| +4% | +$15.2K | 0.05% | 233 |
|
|
2023
Q2 | $373K | Buy |
714
+24
| +3% | +$12.5K | 0.05% | 247 |
|
|
2023
Q1 | $398K | Buy |
690
+75
| +12% | +$43.2K | 0.05% | 220 |
|
|
2022
Q4 | $339K | Buy |
615
+154
| +33% | +$84.8K | 0.05% | 247 |
|
|
2022
Q3 | $234K | Sell |
461
-31
| -6% | -$15.7K | 0.04% | 245 |
|
|
2022
Q2 | $267K | Buy |
492
+43
| +10% | +$23.3K | 0.04% | 233 |
|
|
2022
Q1 | $265K | Sell |
449
-7
| -2% | -$4.13K | 0.05% | 234 |
|
|
2021
Q4 | $304K | Sell |
456
-19
| -4% | -$12.7K | 0.05% | 220 |
|
|
2021
Q3 | $271K | Buy |
475
+41
| +9% | +$23.4K | 0.06% | 215 |
|
|
2021
Q2 | $219K | Buy |
+434
| New | +$219K | 0.05% | 246 |
|